Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Shijiazhuang, China Clinical Trials

A listing of Shijiazhuang, China clinical trials actively recruiting patients volunteers.


Found (1) clinical trials

This is a randomized, double-blind, placebo-controlled, multicenter phase III study. The study population will consist of approximately 1300 subjects with metastatic hormone sensitive prostate cancer (mHSPC), who will be randomized (1:1 ratio) to receive 600 mg (2 x 300 mg tablets) of darolutamide (ODM-201)/placebo twice daily with food, equivalent to ...


1.34 miles

Learn More »